Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
Not used in the past month/occasional |
Once a week or less |
2 - 6 times per week |
Daily |
Base |
Status unknown |
|---|---|---|---|---|---|---|
Czech Republic |
17.3 |
9.8 |
15.0 |
57.8 |
173 |
6 |
Denmark |
0.0 |
5.2 |
17.0 |
77.8 |
270 |
42 |
Germany |
70.6 |
3.9 |
4.6 |
20.9 |
7613 |
0 |
Greece |
11.7 |
6.6 |
15.8 |
65.8 |
647 |
18 |
Cyprus |
3.3 |
1.7 |
10.0 |
85.0 |
60 |
0 |
Latvia |
0.0 |
2.6 |
6.6 |
90.8 |
76 |
14 |
Malta |
7.1 |
3.6 |
2.9 |
86.4 |
140 |
26 |
Netherlands |
6.6 |
0.6 |
6.0 |
86.8 |
620 |
190 |
Slovenia |
11.0 |
4.8 |
12.0 |
72.3 |
400 |
0 |
Slovakia |
1.8 |
7.1 |
9.8 |
81.3 |
112 |
6 |
Finland |
4.0 |
6.9 |
26.7 |
62.4 |
101 |
0 |
Sweden |
4.3 |
0.9 |
13.9 |
80.9 |
115 |
2 |
Bulgaria |
1.4 |
7.1 |
10.3 |
81.2 |
282 |
4 |
Total |
52.7 |
4.1 |
6.7 |
36.5 |
10609 |
308 |
Notes: Only countries where there are clients repored with opiates as primary drug are repored. Source: 2004 Reitox national reports - TDI - outpatient treatment centres – see [Table TDI-17] | ||||||